The third phase of the clinical trials of the vaccine, which was registered last month, starts today.

"We have gathered almost 31,000 people who want to participate, within just 10 days," Murashko told reporters.

Russia is now completing work on a new mobile application that would enable direct contact between patients and vaccine developers, Murashko said, praising it as "the first experience of this kind in the world."